Global Blood Screening Typing Market
Global Blood Screening Typing Market

Blood Screening Typing Comprehensive Study by Type (Reagents & Kits, Instruments, Software & Services), End-users (Hospitals, Blood Banks, Clinical Laboratories, Other), Blood (Type A, Type B, Type AB, Type O) Players and Region - Global Market Outlook to 2027

Blood Screening Typing Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 244 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Blood Screening Typing?
Blood screening typing is a test that determines a personís blood type. The test is essential if need a blood transfusion or are planning to donate blood. Not all blood types are compatible, so itís important to know blood group. Receiving blood thatís incompatible with blood type could trigger a dangerous immune response. Blood screening typing is done prior to a blood transfusion or when classifying a personís blood for donation. Blood typing is a fast and easy way to ensure that receive the right kind of blood during surgery or after an injury. Blood screening typing is especially important for pregnant women.

The market study is broken down by Type (Reagents & Kits, Instruments and Software & Services) and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Blood Screening Typing market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Agena Bioscience, Inc. (United States), Beckman Coulter. (United States), Bio-Rad Laboratories, Inc. (United States), DAY MEDICAL SA. (Switzerland), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA. (Germany), Quotient, Ltd. (Switzerland), Abbott Laboratories, Inc. (United States) and F. Hoffmann-La Roche Ltd. (Switzerland) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Blood Screening Typing market by Type, Application and Region.

On the basis of geography, the market of Blood Screening Typing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Blood Screening Typing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Blood, the sub-segment i.e. Type A will boost the Blood Screening Typing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
Bio-Rad Laboratories, Inc. a global leader of life science research and clinical diagnostic products, acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.

The FDA Center for Biologics Evaluation and Research, or CBER, Office of Blood Research and Review, called OBRR, reviews several different types of regulatory applications with respect to blood and blood components. This includes biologics license applications, called BLAs, which represent the regulatory pathway for blood components. The BLA regulatory process also applies to biological drugs such as fractionated plasma products.

Market Trend
  • Technological Advancements in Blood Screening Methods

Market Drivers
  • Increasing need for Blood Transfusion in Critical Patients

Opportunities
  • Increasing Healthcare Expenditure

Restraints
  • Lack Proper Healthcare Facilities
  • Lack of Skilled Professionals

Challenges
  • The Availability of Rare Antiserum
  • Blood Typing of Recently-transfused Patients and for those having a Positive Anti-globulin Test


Key Target Audience
Manufacturers of Blood Screening Typing Products, Vendors and distributors of Blood Screening Typing Products, Hospitals and Clinics, Blood Banks, Research Institutes, Venture capitalists and investors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Agena Bioscience, Inc. (United States), Beckman Coulter. (United States), Bio-Rad Laboratories, Inc. (United States), DAY MEDICAL SA. (Switzerland), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA. (Germany), Quotient, Ltd. (Switzerland), Abbott Laboratories, Inc. (United States) and F. Hoffmann-La Roche Ltd. (Switzerland) etc.

2. Can we have customized study for Blood Screening Typing Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Blood Screening Typing Market by 2027?
Analysts at AMA estimates Blood Screening Typing Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Type
  • Reagents & Kits
  • Instruments
  • Software & Services
By End-users
  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Other

By Blood
  • Type A
  • Type B
  • Type AB
  • Type O

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing need for Blood Transfusion in Critical Patients
    • 3.3. Market Challenges
      • 3.3.1. The Availability of Rare Antiserum
      • 3.3.2. Blood Typing of Recently-transfused Patients and for those having a Positive Anti-globulin Test
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Blood Screening Methods
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Screening Typing, by Type, End-users, Blood and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Blood Screening Typing (Value)
      • 5.2.1. Global Blood Screening Typing by: Type (Value)
        • 5.2.1.1. Reagents & Kits
        • 5.2.1.2. Instruments
        • 5.2.1.3. Software & Services
      • 5.2.2. Global Blood Screening Typing by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Blood Banks
        • 5.2.2.3. Clinical Laboratories
        • 5.2.2.4. Other
      • 5.2.3. Global Blood Screening Typing by: Blood (Value)
        • 5.2.3.1. Type A
        • 5.2.3.2. Type B
        • 5.2.3.3. Type AB
        • 5.2.3.4. Type O
      • 5.2.4. Global Blood Screening Typing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Blood Screening Typing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agena Bioscience, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beckman Coulter. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DAY MEDICAL SA. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Grifols, S.A. (Spain)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Immucor, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA. (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quotient, Ltd. (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abbott Laboratories, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Screening Typing Sale, by Type, End-users, Blood and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Blood Screening Typing (Value)
      • 7.2.1. Global Blood Screening Typing by: Type (Value)
        • 7.2.1.1. Reagents & Kits
        • 7.2.1.2. Instruments
        • 7.2.1.3. Software & Services
      • 7.2.2. Global Blood Screening Typing by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Blood Banks
        • 7.2.2.3. Clinical Laboratories
        • 7.2.2.4. Other
      • 7.2.3. Global Blood Screening Typing by: Blood (Value)
        • 7.2.3.1. Type A
        • 7.2.3.2. Type B
        • 7.2.3.3. Type AB
        • 7.2.3.4. Type O
      • 7.2.4. Global Blood Screening Typing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Screening Typing: by Type(USD Million)
  • Table 2. Blood Screening Typing Reagents & Kits , by Region USD Million (2016-2021)
  • Table 3. Blood Screening Typing Instruments , by Region USD Million (2016-2021)
  • Table 4. Blood Screening Typing Software & Services , by Region USD Million (2016-2021)
  • Table 5. Blood Screening Typing: by End-users(USD Million)
  • Table 6. Blood Screening Typing Hospitals , by Region USD Million (2016-2021)
  • Table 7. Blood Screening Typing Blood Banks , by Region USD Million (2016-2021)
  • Table 8. Blood Screening Typing Clinical Laboratories , by Region USD Million (2016-2021)
  • Table 9. Blood Screening Typing Other , by Region USD Million (2016-2021)
  • Table 10. Blood Screening Typing: by Blood(USD Million)
  • Table 11. Blood Screening Typing Type A , by Region USD Million (2016-2021)
  • Table 12. Blood Screening Typing Type B , by Region USD Million (2016-2021)
  • Table 13. Blood Screening Typing Type AB , by Region USD Million (2016-2021)
  • Table 14. Blood Screening Typing Type O , by Region USD Million (2016-2021)
  • Table 15. South America Blood Screening Typing, by Country USD Million (2016-2021)
  • Table 16. South America Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 17. South America Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 18. South America Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 19. Brazil Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 20. Brazil Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 21. Brazil Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 22. Argentina Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 23. Argentina Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 24. Argentina Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 25. Rest of South America Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 26. Rest of South America Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 27. Rest of South America Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 28. Asia Pacific Blood Screening Typing, by Country USD Million (2016-2021)
  • Table 29. Asia Pacific Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 30. Asia Pacific Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 31. Asia Pacific Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 32. China Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 33. China Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 34. China Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 35. Japan Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 36. Japan Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 37. Japan Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 38. India Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 39. India Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 40. India Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 41. South Korea Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 42. South Korea Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 43. South Korea Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 44. Australia Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 45. Australia Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 46. Australia Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 50. Europe Blood Screening Typing, by Country USD Million (2016-2021)
  • Table 51. Europe Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 52. Europe Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 53. Europe Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 54. Germany Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 55. Germany Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 56. Germany Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 57. France Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 58. France Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 59. France Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 60. Italy Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 61. Italy Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 62. Italy Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 63. United Kingdom Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 64. United Kingdom Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 65. United Kingdom Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 66. Netherlands Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 67. Netherlands Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 68. Netherlands Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 69. Rest of Europe Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 70. Rest of Europe Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 71. Rest of Europe Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 72. MEA Blood Screening Typing, by Country USD Million (2016-2021)
  • Table 73. MEA Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 74. MEA Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 75. MEA Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 76. Middle East Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 77. Middle East Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 78. Middle East Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 79. Africa Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 80. Africa Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 81. Africa Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 82. North America Blood Screening Typing, by Country USD Million (2016-2021)
  • Table 83. North America Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 84. North America Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 85. North America Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 86. United States Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 87. United States Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 88. United States Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 89. Canada Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 90. Canada Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 91. Canada Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 92. Mexico Blood Screening Typing, by Type USD Million (2016-2021)
  • Table 93. Mexico Blood Screening Typing, by End-users USD Million (2016-2021)
  • Table 94. Mexico Blood Screening Typing, by Blood USD Million (2016-2021)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Blood Screening Typing: by Type(USD Million)
  • Table 106. Blood Screening Typing Reagents & Kits , by Region USD Million (2022-2027)
  • Table 107. Blood Screening Typing Instruments , by Region USD Million (2022-2027)
  • Table 108. Blood Screening Typing Software & Services , by Region USD Million (2022-2027)
  • Table 109. Blood Screening Typing: by End-users(USD Million)
  • Table 110. Blood Screening Typing Hospitals , by Region USD Million (2022-2027)
  • Table 111. Blood Screening Typing Blood Banks , by Region USD Million (2022-2027)
  • Table 112. Blood Screening Typing Clinical Laboratories , by Region USD Million (2022-2027)
  • Table 113. Blood Screening Typing Other , by Region USD Million (2022-2027)
  • Table 114. Blood Screening Typing: by Blood(USD Million)
  • Table 115. Blood Screening Typing Type A , by Region USD Million (2022-2027)
  • Table 116. Blood Screening Typing Type B , by Region USD Million (2022-2027)
  • Table 117. Blood Screening Typing Type AB , by Region USD Million (2022-2027)
  • Table 118. Blood Screening Typing Type O , by Region USD Million (2022-2027)
  • Table 119. South America Blood Screening Typing, by Country USD Million (2022-2027)
  • Table 120. South America Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 121. South America Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 122. South America Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 123. Brazil Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 124. Brazil Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 125. Brazil Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 126. Argentina Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 127. Argentina Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 128. Argentina Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 129. Rest of South America Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 130. Rest of South America Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 131. Rest of South America Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 132. Asia Pacific Blood Screening Typing, by Country USD Million (2022-2027)
  • Table 133. Asia Pacific Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 134. Asia Pacific Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 135. Asia Pacific Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 136. China Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 137. China Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 138. China Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 139. Japan Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 140. Japan Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 141. Japan Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 142. India Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 143. India Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 144. India Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 145. South Korea Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 146. South Korea Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 147. South Korea Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 148. Australia Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 149. Australia Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 150. Australia Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 154. Europe Blood Screening Typing, by Country USD Million (2022-2027)
  • Table 155. Europe Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 156. Europe Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 157. Europe Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 158. Germany Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 159. Germany Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 160. Germany Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 161. France Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 162. France Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 163. France Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 164. Italy Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 165. Italy Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 166. Italy Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 167. United Kingdom Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 168. United Kingdom Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 169. United Kingdom Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 170. Netherlands Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 171. Netherlands Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 172. Netherlands Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 173. Rest of Europe Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 174. Rest of Europe Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 175. Rest of Europe Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 176. MEA Blood Screening Typing, by Country USD Million (2022-2027)
  • Table 177. MEA Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 178. MEA Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 179. MEA Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 180. Middle East Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 181. Middle East Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 182. Middle East Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 183. Africa Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 184. Africa Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 185. Africa Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 186. North America Blood Screening Typing, by Country USD Million (2022-2027)
  • Table 187. North America Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 188. North America Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 189. North America Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 190. United States Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 191. United States Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 192. United States Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 193. Canada Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 194. Canada Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 195. Canada Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 196. Mexico Blood Screening Typing, by Type USD Million (2022-2027)
  • Table 197. Mexico Blood Screening Typing, by End-users USD Million (2022-2027)
  • Table 198. Mexico Blood Screening Typing, by Blood USD Million (2022-2027)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Screening Typing: by Type USD Million (2016-2021)
  • Figure 5. Global Blood Screening Typing: by End-users USD Million (2016-2021)
  • Figure 6. Global Blood Screening Typing: by Blood USD Million (2016-2021)
  • Figure 7. South America Blood Screening Typing Share (%), by Country
  • Figure 8. Asia Pacific Blood Screening Typing Share (%), by Country
  • Figure 9. Europe Blood Screening Typing Share (%), by Country
  • Figure 10. MEA Blood Screening Typing Share (%), by Country
  • Figure 11. North America Blood Screening Typing Share (%), by Country
  • Figure 12. Global Blood Screening Typing share by Players 2021 (%)
  • Figure 13. Global Blood Screening Typing share by Players (Top 3) 2021(%)
  • Figure 14. Global Blood Screening Typing share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Agena Bioscience, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Agena Bioscience, Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Beckman Coulter. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Beckman Coulter. (United States) Revenue: by Geography 2021
  • Figure 20. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 22. DAY MEDICAL SA. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. DAY MEDICAL SA. (Switzerland) Revenue: by Geography 2021
  • Figure 24. Grifols, S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 25. Grifols, S.A. (Spain) Revenue: by Geography 2021
  • Figure 26. Immucor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Immucor, Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Merck KGaA. (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Merck KGaA. (Germany) Revenue: by Geography 2021
  • Figure 30. Quotient, Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Quotient, Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 32. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 34. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 36. Global Blood Screening Typing: by Type USD Million (2022-2027)
  • Figure 37. Global Blood Screening Typing: by End-users USD Million (2022-2027)
  • Figure 38. Global Blood Screening Typing: by Blood USD Million (2022-2027)
  • Figure 39. South America Blood Screening Typing Share (%), by Country
  • Figure 40. Asia Pacific Blood Screening Typing Share (%), by Country
  • Figure 41. Europe Blood Screening Typing Share (%), by Country
  • Figure 42. MEA Blood Screening Typing Share (%), by Country
  • Figure 43. North America Blood Screening Typing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Agena Bioscience, Inc. (United States)
  • Beckman Coulter. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • DAY MEDICAL SA. (Switzerland)
  • Grifols, S.A. (Spain)
  • Immucor, Inc. (United States)
  • Merck KGaA. (Germany)
  • Quotient, Ltd. (Switzerland)
  • Abbott Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation